BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24264531)

  • 1. Central neurotoxicity of standard treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal study.
    Froklage FE; Oosterbaan LJ; Sizoo EM; de Groot M; Bosma I; Sanchez E; Douw L; Heimans JJ; Reijneveld JC; Lagerwaard FJ; Buter J; Uitdehaag BM; Klein M; Postma TJ
    J Neurooncol; 2014 Jan; 116(2):387-94. PubMed ID: 24264531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings.
    Hilverda K; Bosma I; Heimans JJ; Postma TJ; Peter Vandertop W; Slotman BJ; Buter J; Reijneveld JC; Klein M
    J Neurooncol; 2010 Mar; 97(1):89-94. PubMed ID: 19718545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation induced early necrosis in patients with malignant gliomas receiving temozolomide.
    Yaman E; Buyukberber S; Benekli M; Oner Y; Coskun U; Akmansu M; Ozturk B; Kaya AO; Uncu D; Yildiz R
    Clin Neurol Neurosurg; 2010 Oct; 112(8):662-7. PubMed ID: 20627551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temozolomide during and after radiation therapy for WHO grade III gliomas: preliminary report of a prospective multicenter study.
    Kim YH; Park CK; Cho WH; Kim IA; Moon S; Choe G; Park SH; Kim IH; Kim DG; Jung HW; Lee MM; Bae SH; Cha SH; Kim CY
    J Neurooncol; 2011 Jul; 103(3):503-12. PubMed ID: 20862518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal study of cognitive function in glioma patients treated with modern radiotherapy techniques and standard chemotherapy.
    Rydelius A; Lätt J; Kinhult S; Engelholm S; Van Westen D; Pihlsgård M; Bengzon J; Sundgren PC; Lilja Å
    Acta Oncol; 2020 Sep; 59(9):1091-1097. PubMed ID: 32847475
    [No Abstract]   [Full Text] [Related]  

  • 6. Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children.
    Broniscer A; Chintagumpala M; Fouladi M; Krasin MJ; Kocak M; Bowers DC; Iacono LC; Merchant TE; Stewart CF; Houghton PJ; Kun LE; Ledet D; Gajjar A
    J Neurooncol; 2006 Feb; 76(3):313-9. PubMed ID: 16200343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy followed by adjuvant temozolomide treatment of malignant glioma.
    Yang TM; Wang HC; Lin YJ; Lin WC; Lu CH; Chang WN; Chang HW; Ho JT
    Surg Neurol; 2008 Dec; 70 Suppl 1():S1:60-3. PubMed ID: 19061770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined radiotherapy and temozolomide in patients with recurrent high grade glioma.
    Schönekaes K; Mücke R; Panke J; Rama B; Wagner W
    Tumori; 2002; 88(1):28-31. PubMed ID: 12004846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up.
    Douw L; Klein M; Fagel SS; van den Heuvel J; Taphoorn MJ; Aaronson NK; Postma TJ; Vandertop WP; Mooij JJ; Boerman RH; Beute GN; Sluimer JD; Slotman BJ; Reijneveld JC; Heimans JJ
    Lancet Neurol; 2009 Sep; 8(9):810-8. PubMed ID: 19665931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy.
    Charnley N; West CM; Barnett CM; Brock C; Bydder GM; Glaser M; Newlands ES; Swindell R; Matthews J; Price P
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):331-8. PubMed ID: 16839701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
    Wick W; Hartmann C; Engel C; Stoffels M; Felsberg J; Stockhammer F; Sabel MC; Koeppen S; Ketter R; Meyermann R; Rapp M; Meisner C; Kortmann RD; Pietsch T; Wiestler OD; Ernemann U; Bamberg M; Reifenberger G; von Deimling A; Weller M
    J Clin Oncol; 2009 Dec; 27(35):5874-80. PubMed ID: 19901110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-intensity temozolomide after concurrent chemoradiotherapy in operated high-grade gliomas.
    Dall'oglio S; D'Amico A; Pioli F; Gabbani M; Pasini F; Passarin MG; Talacchi A; Turazzi S; Maluta S
    J Neurooncol; 2008 Dec; 90(3):315-9. PubMed ID: 18688571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas.
    Nayak L; de Groot J; Wefel JS; Cloughesy TF; Lieberman F; Chang SM; Omuro A; Drappatz J; Batchelor TT; DeAngelis LM; Gilbert MR; Aldape KD; Yung AW; Fisher J; Ye X; Chen A; Grossman S; Prados M; Wen PY
    J Neurooncol; 2017 Mar; 132(1):181-188. PubMed ID: 28116649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.
    Perry JR; Bélanger K; Mason WP; Fulton D; Kavan P; Easaw J; Shields C; Kirby S; Macdonald DR; Eisenstat DD; Thiessen B; Forsyth P; Pouliot JF
    J Clin Oncol; 2010 Apr; 28(12):2051-7. PubMed ID: 20308655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation combined with temozolomide contraindicated for young adults diagnosed with anaplastic glioma.
    Yang P; Zhang C; Cai J; You G; Wang Y; Qiu X; Li S; Wu C; Yao K; Li W; Peng X; Zhang W; Jiang T
    Oncotarget; 2016 Nov; 7(48):80091-80100. PubMed ID: 27590514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma.
    Han SJ; Rolston JD; Molinaro AM; Clarke JL; Prados MD; Chang SM; Berger MS; DeSilva A; Butowski NA
    Neuro Oncol; 2014 Sep; 16(9):1255-62. PubMed ID: 24670608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The outcomes of concomitant radiation plus temozolomide followed by adjuvant temozolomide for newly diagnosed high grade gliomas: the preliminary results of single center prospective study.
    Shawky H; Abo Hamar AH; Galal S; Zakaria F; El-Shorbagy D
    J Egypt Natl Canc Inst; 2009 Jun; 21(2):107-19. PubMed ID: 21057562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temozolomide in newly diagnosed malignant gliomas: administered concomitantly with radiotherapy, and thereafter as consolidation treatment.
    Yaman E; Buyukberber S; Uner A; Coskun U; Akmansu M; Benekli M; Yamac D; Ozturk B; Kaya AO; Yildiz R; Ozkan S; Gunel N
    Onkologie; 2008 Jun; 31(6):309-13. PubMed ID: 18547971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-grade gliomas: results in patients treated with adjuvant radiotherapy alone and with adjuvant radio-chemotherapy.
    Valeriani M; Ferretti A; Franzese P; Tombolini V
    Anticancer Res; 2006; 26(3B):2429-35. PubMed ID: 16821628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.